agilon health still looks cheap if its enterprise value is really about $1.5 billion and it hits its projected numbers. Its recent rise looks driven more by EBITDA growth than revenue growth. x.com 

UnitedHealth is cheap against its earnings at about 17 times next year's, while health insurers usually get 20 times. Twenty times next year's estimated $22.55 per share, give or take 12%, puts fair value at about $396.80-$505.02, above the $376.30 price; it turns expensive above $435.96. The forward read leans on a forecast 45% above trailing earnings. This is a levels-only screen off reported earnings and revenue estimates, with no fundamental work. x.com 

UnitedHealth may be trading at a discount, with a price-to-sales ratio of 0.60x versus its 10-year average of 1.19x. x.com 

Alignment Healthcare's 25x multiple is nothing for a company growing its top line 20%+, with just 1% market share and a better model. @JasperRidley counters that few health insurers trade at 25x EBITDA. x.com